Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

glucocorticoid

glucocorticoid is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 3
News articles 0
Drug details — glucocorticoid
Class
—
Route
—
Patents
20
Programs
3
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

glucocorticoid is an FDA-listed pharmaceutical active ingredient.

Key facts

INN glucocorticoid

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. APHP200026 Phase 3 · PARItec · Patients with GPA and inadequate response to standard of car
  2. CD25 antibody combined glucocorticoid as first-line treatment Phase 2 · Chinese Academy of · Acute Graft Versus Host Disease
  3. glucocorticoid plus iguratimod Unknown · Peking University Biologics · Autoimmune Diseases

Related patents

Browse patents

  1. US 12410209

    Modified glucocorticoids

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12370188

    Formulations of dazucorilant, a glucocorticoid receptor modulator

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12370175

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12285425

    Glucocorticoid receptor modulators to treat cervical cancer

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12263169

    Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12226417

    Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12226412

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12171760

    Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12152028

    Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12144812

    Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12139486

    Octahydro fused azadecalin glucocorticoid receptor modulators

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12109272

    Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12102642

    Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12098141

    Bicyclic indazole glucocorticoid receptor antagonists

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12098144

    Piperazine indazole glucocorticoid receptor antagonists

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12097210

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12018001

    Pyrimidine cyclohexenyl glucocorticoid receptor modulators

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12011450

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11998606

    Compounds and methods for selective proteolysis of glucocorticoid receptors

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11969435

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is glucocorticoid?

glucocorticoid is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.